142 related articles for article (PubMed ID: 12857571)
1. Hypereosinophilia with abnormal T cells, trisomy 7 and elevated TARC serum level.
Roumier AS; Grardel N; Laï JL; Becqueriaux I; Ghomari K; de Lavareille A; Roufosse F; Prin L; Capron M
Haematologica; 2003 Jul; 88(7):ECR24. PubMed ID: 12857571
[TBL] [Abstract][Full Text] [Related]
2. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia.
Simon HU; Plötz SG; Dummer R; Blaser K
N Engl J Med; 1999 Oct; 341(15):1112-20. PubMed ID: 10511609
[TBL] [Abstract][Full Text] [Related]
3. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo.
de Lavareille A; Roufosse F; Schandené L; Stordeur P; Cogan E; Goldman M
Eur J Immunol; 2001 Apr; 31(4):1037-46. PubMed ID: 11298328
[TBL] [Abstract][Full Text] [Related]
4. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
[TBL] [Abstract][Full Text] [Related]
5. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
Shimada Y; Takehara K; Sato S
J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
[TBL] [Abstract][Full Text] [Related]
6. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes.
Bank I; Amariglio N; Reshef A; Hardan I; Confino Y; Trau H; Shtrasburg S; Langevitz P; Monselise Y; Shalit M; Rechavi G
Leuk Lymphoma; 2001 Jun; 42(1-2):123-33. PubMed ID: 11699199
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic evaluation of circulating T-cell clones in hypereosinophilic syndromes with or without abnormal CD3 and CD4 lymphocytes.
Bassan R; Locatelli G; Borleri G; Salvi A; Barbui T
Haematologica; 2004 Feb; 89(2):238-9. PubMed ID: 15003902
[No Abstract] [Full Text] [Related]
8. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome.
de Lavareille A; Roufosse F; Schmid-Grendelmeier P; Roumier AS; Schandené L; Cogan E; Simon HU; Goldman M
J Allergy Clin Immunol; 2002 Sep; 110(3):476-9. PubMed ID: 12209097
[TBL] [Abstract][Full Text] [Related]
9. [Chronic hypereosinophilia: a model of Th2 disorders].
Roufosse F; Schandené L; Cogan E; Goldman M
Rev Prat; 2000 Mar; 50(6):622-6. PubMed ID: 10808318
[TBL] [Abstract][Full Text] [Related]
10. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome.
Roufosse F; Schandené L; Sibille C; Willard-Gallo K; Kennes B; Efira A; Goldman M; Cogan E
Br J Haematol; 2000 Jun; 109(3):540-8. PubMed ID: 10886202
[TBL] [Abstract][Full Text] [Related]
11. Altered cytokine expression in mesenteric lymph nodes in a rat strain (Matsumoto Eosinophilic Shinshu) that spontaneously develops hypereosinophilia.
Muto S; Monnai M; Okuhara Y; Murakami M; Kuroda J; Ono T; Matsumoto K
Immunology; 2005 Nov; 116(3):373-80. PubMed ID: 16236127
[TBL] [Abstract][Full Text] [Related]
12. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
13. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases.
Echigo T; Hasegawa M; Shimada Y; Inaoki M; Takehara K; Sato S
Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210
[TBL] [Abstract][Full Text] [Related]
14. Cyclical hypereosinophilia with skin manifestations and a clonal T cell population.
González Delgado P; de la Sen Fernández ML; Soriano Gomis V; Pérez Crespo M; Muñoz Ruiz C; Hernández Niveiro E
J Investig Allergol Clin Immunol; 2008; 18(5):401-3. PubMed ID: 18973106
[TBL] [Abstract][Full Text] [Related]
15. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
16. CD3
Carpentier C; Schandené L; Dewispelaere L; Heimann P; Cogan E; Roufosse F
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2426-2439.e7. PubMed ID: 33545400
[TBL] [Abstract][Full Text] [Related]
17. More than 13 years of hypereosinophila associated with clonal CD3-CD4+ lymphocytosis of TH2/TH0 type.
Sugimoto K; Tamayose K; Sasaki M; Danbara T; Aikawa Y; Ogawa H; Sato N; Tashiro E; Oshimi K
Int J Hematol; 2002 Apr; 75(3):281-4. PubMed ID: 11999356
[TBL] [Abstract][Full Text] [Related]
18. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
19. Hypereosinophilic syndromes.
Roufosse FE; Goldman M; Cogan E
Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
[TBL] [Abstract][Full Text] [Related]
20. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome.
Cogan E; Schandené L; Crusiaux A; Cochaux P; Velu T; Goldman M
N Engl J Med; 1994 Feb; 330(8):535-8. PubMed ID: 8302319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
